Eisai wins approval to use Aricept for DLB treatment in Philippines

HI-Eisai Pharmaceutical, a subsidiary of Eisai in the Philippines, has obtained approval for a new indication Aricept (donepezil hydrochloride) to treat dementia with Lewy bodies (DLB).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news